DESIGN AND OPTIMIZATION OF THE VARIABLES IN THE ADSORPTIVE STRIPPING VOLTAMMETRIC DETERMINATION OF RUFLOXACIN IN TABLETS, HUMAN PLASMA AND URINE

被引:27
作者
FURLANETTO, S
GRATTERI, P
PINZAUTI, S
LEARDI, R
DREASSI, E
SANTONI, G
机构
[1] GENET UNIT,IST ANAL & TECNOL FARMACEUT & ALIMENTARI,I-16147 GENOA,ITALY
[2] UNIV SIENA,DIPARTIMENTO FARMACO CHIM TECNOL,I-53100 SIENA,ITALY
[3] STABILIMENTO CHIM FARMACEUT MIL,I-50141 FLORENCE,ITALY
关键词
ADSORPTIVE STRIPPING VOLTAMMETRY; RUFLOXACIN; HUMAN PLASMA AND URINE ANALYSIS; EXPERIMENTAL DESIGN; REGRESSION MODELING; RESPONSE SURFACE PLOT; HPLC DETERMINATION;
D O I
10.1016/0731-7085(95)01288-V
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An adsorptive stripping voltammetric method with a hanging mercury drop electrode was developed for the determination of the fluoroquinolone rufloxacin in tablets, human plasma and urine. Measurements were obtained in differential pulse mode and a multivariate strategy was used to optimize the variables involved. Besides the independent effects of the variables, a strong interaction between scan rate and pulse duration has been found. Rufloxacin was analysed at concentrations between 1.7 x 10(-8) and 1.9 x 10(-7) M with a detection limit of 9.2 x 10(-9) M. Diluted tablet solutions and urine samples were analysed directly, while plasma samples needed an extraction procedure before voltammetric analysis. An improved HPLC procedure was used as comparative method.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 11 条
[1]  
CARLSON R, 1992, DESIGN OPTIMIZATION, P59
[2]   ANALYTICAL PROCEDURE FOR THE DETERMINATION OF RUFLOXACIN, A NEW PYRIDOBENZOTHIAZINE, IN HUMAN SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CARLUCCI, G ;
PALUMBO, G .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 564 (01) :346-351
[3]   DETERMINATION OF RUFLOXACIN, A NEW TRICYCLIC FLUOROQUINOLONE IN BIOLOGICAL-FLUIDS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
CARLUCCI, G ;
MAZZEO, P ;
FANINI, D ;
PALUMBO, G .
THERAPEUTIC DRUG MONITORING, 1991, 13 (05) :448-451
[5]  
GRATTERI P, IN PRESS ELECTROANAL
[6]   MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF RUFLOXACIN IN NORMAL VOLUNTEERS [J].
KISICKI, JC ;
GRIESS, RS ;
OTT, CL ;
COHEN, GM ;
MCCORMACK, RJ ;
TROETEL, WM ;
IMBIMBO, BP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1296-1301
[7]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF RUFLOXACIN AND ITS MAIN ACTIVE METABOLITE IN BIOLOGICAL-FLUIDS [J].
LOMBARDI, F ;
ARDEMAGNI, R ;
COLZANI, V ;
VISCONTI, M .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 576 (01) :129-134
[8]   THE ANALYTICAL PROFILE OF RUFLOXACIN, A NEW FLUOROQUINOLONE, BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
QUAGLIA, MG ;
FARINA, A ;
MELCHIORRE, P ;
BOSSU, E ;
PAGELLA, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :1075-1078
[9]  
QUAGLIA MG, 1991, FARMACO, V46, P979
[10]   ANALYSIS OF URINARY-TRACT ANTIBACTERIAL AGENTS IN PHARMACEUTICAL DOSAGE FORM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
SONDACK, DL ;
KOCH, WL .
JOURNAL OF CHROMATOGRAPHY, 1977, 132 (02) :352-355